Home Capital Broker's Calls

UOB Kay Hian initiates coverage on Aoxin with "buy" call and 37 cents target price

The Edge Singapore
The Edge Singapore11/19/2021 10:48 AM GMT+08  • 2 min read
UOB Kay Hian initiates coverage on Aoxin with "buy" call and 37 cents target price
Cheong also expects Aoxin to have the potential to expand into providing Covid-19 ART testing services, further lifting earnings
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

UOB Kay Hian analyst John Cheong has initiated coverage on Aoxin Q & M Dental Group with a “buy” call and 37 cents target price, on bullish expectations that the company will see a turnaround led by strong contributions from its newly-acquired business in China.

Cheong expects Aoxin, which runs 16 dental centres in eight cities in China, to report FY2022 earnings of $12 million, versus a loss of $0.1 million in FY2021.

See: Analysts see Q&M subsidiary's acquisition of Acumen as positive; Maybank KE lifts TP to $1.03

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.